| Contrat (Sanofi) - Fournir des vaccins contre la coquelucheCW2445895:0 | Department of Public Works and Government Services (PSPC) | 37,8 M $ | 27 mars 2026 |
| Modif 004 - Vaccins contre le méningocoque C et quadrivalents - SanofiCW2270377:3 | Department of Public Works and Government Services (PSPC) | 0 $ | 25 janv. 2023 |
| Modif 003 - Préparation et vaccins contre la grippe pandémique de réserve - SANOFI PASTEUR LIMITEE6D142-214313:001:PH:1 | Department of Public Works and Government Services (PSPC) | 7,3 M $ | 17 mai 2022 |
| Modif 008 - Vaccin antirabique - SANOFI PASTEUR LIMITEEE60PH-22RABV/001/PH:7 | Department of Public Works and Government Services (PSPC) | 6 M $ | 22 mars 2022 |
| Modif 002 - Vaccin contre la typhoïde - SANOFI PASTEUR LIMITED-SANOFI PASTEUR LIMITEEE60PH-22TYPH:001:PH:2 | Department of Public Works and Government Services (PSPC) | 134,6 k $ | 9 mars 2022 |
| Modif 003 - Vaccins annuels antigrippal - SANOFI PASTEUR LIMITED-SANOFI PASTEUR LIMITEEE60PH-22GFLU:001:PH:2 | Department of Public Works and Government Services (PSPC) | 46 M $ | 25 févr. 2022 |
| Modif 004 - FLUZONE HD - SANOFI PASTEUR LIMITED-SANOFI PASTEUR LIMITEEE60PH-22FHLD:001:PH:2 | Department of Public Works and Government Services (PSPC) | 81,5 M $ | 23 févr. 2022 |
| Modif 005 - Fournisseur Unique Sanofi Pasteur (FUSP) - Sanofi Pasteur Lt.E60PH-21SPSS:001:PH:2 | Department of Public Works and Government Services (PSPC) | 205,6 k $ | 10 févr. 2021 |
| Modif 011 - VACCINS CONTRE LA COQUELUCHE - SANOFI PASTEUR LIMITEEE60PH-21PERT:001:PH:4 | Department of Public Works and Government Services (PSPC) | 171,5 k $ | 5 janv. 2021 |
| Produits pharmaceutiques et biologiques6D024-194472:001:PH:0 | Public Works and Government Services Canada | 340,2 k $ | 27 avr. 2020 |
| Produits pharmaceutiques et biologiquesE60PH-19FLHD:001:PH:0 | Public Works and Government Services Canada | 40,2 M $ | 29 avr. 2019 |
| Produits pharmaceutiques et biologiquesE60PH-19GFLU:002:PH:0 | Public Works and Government Services Canada | 26,7 M $ | 27 févr. 2019 |
| Produits pharmaceutiques et biologiquesE60PH-19TYPH:001:PH:0 | Public Works and Government Services Canada | 131,9 k $ | 6 déc. 2018 |
| Produits pharmaceutiques et biologiques6D024-164331:001:PH:0 | Public Works and Government Services Canada | 295,2 k $ | 7 févr. 2018 |
| Source unique Sanofi Pasteur (SUSP)E60PH-17SPSS:001:PH:0 | Public Works and Government Services Canada | 18,2 M $ | 1 mars 2017 |
| Produits pharmaceutiques et biologiquesE60PH-17RIGG:002:PH:0 | Public Works and Government Services Canada | 1,5 M $ | 3 févr. 2017 |
| vaccin anti-meningococciques quadrivalentE60PH-17MENQ:001:PH:0 | Public Works and Government Services Canada | 11,8 M $ | 3 févr. 2017 |
| Vaccin contre la rageE60PH-17RABV:001:PH:0 | Public Works and Government Services Canada | 1,7 M $ | 30 janv. 2017 |
| Vaccin typhoïdiqueE60PH-16TYPH:001:PH:0 | Public Works and Government Services Canada | 115,6 k $ | 5 janv. 2016 |
| VACCINS CONTRE LA COQUELUCHEE60PH-16PERT:001:PH:0 | Public Works and Government Services Canada | 138,2 M $ | 23 oct. 2015 |